"Leave Nothing Behind": Strategy of Choice for Small Coronaries?
- PMID: 33248980
- DOI: 10.1016/j.jcin.2020.09.016
"Leave Nothing Behind": Strategy of Choice for Small Coronaries?
Keywords: angioplasty; drug-coated balloon; stents.
Conflict of interest statement
Author Disclosures Dr. Kereiakes is a consultant for SINO Medical Sciences Technologies, Inc., Boston Scientific, Elixir Medical, Svelte Medical Systems, Inc., Caliber Therapeutics/Orchestra Biomed, and Shockwave Medical; and is a stockholder in Ablative Solutions, Inc.
Comment on
-
Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial.JACC Cardiovasc Interv. 2020 Dec 28;13(24):2840-2849. doi: 10.1016/j.jcin.2020.08.035. Epub 2020 Nov 25. JACC Cardiovasc Interv. 2020. PMID: 33248978 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
